
OMERACT
@omeract
Standardizing outcomes for use in rheumatology clinical trials around the world
ID: 1668103188
http://www.omeract.org 13-08-2013 15:45:34
548 Tweet
2,2K Followers
2,2K Following






Honored and humbled to be inducted as a Master at this yearās #ACR24 #ARPRheum annual meeting. So great to connect with so many who helped me āsproutā including Johns Hopkins Rheumatology McGill Medicine and Health Sciences Arthritis Research Canada CATCH Cohort Canada OMERACT in DC, and be able to stay with my daughter!



OMERACT Working Group members (Dr Robin Christensen, BSc, MSc, PhD & Marissa Lassere) have contributed to the development of both the SPIRIT-Surrogate and CONSORT-Surrogate outcome guidelines, aimed at enhancing the rigour and transparency of trials that employ surrogate endpoints. Randomized

In its recent report, Guidance for Best Practices for Clinical Trials, the World Health Organization (WHO) advocates for the use of Core Outcome Sets in clinical trials. Core Outcome Sets represent a minimum set of outcomes that must be measured in all trials, ensuring consistency and standardization








